S. no | Drug name | Clinical trial | Trial | Treatment | References |
---|---|---|---|---|---|
1. | Pacritinib | Phase 3 | NCT04404361 | Kinase inhibitor | [170] |
2. | Enoxaparin | Phase 3 | NCT04401293 | Antithrombotic | [171] |
3. | Remdesivir + Baricitinib | Phase 3 | NCT04401579 | Antiviral | [172] |
4. | Remdesivir | Phase 3 | NCT04401579 | Antiviral | [172] |
5. | Hydroxychloroquine | Phase 3 | NCT04410562 | Antimalarial | [173] |
6. | Favipiravir + Hydroxychloroquine | Phase 3 | NCT04411433 | Antiviral | |
7. | ASC09 + Oseltamivir | Phase 3 | NCT04261270 | Antiviral | [176] |
8. | ASC09 + Ritonavir | NA | NCT04261907 | Antiviral | [176] |
9. | Tocilizumab (IL-6) | Phase 3 | NCT04412772 | Monoclonal antibodies | [177] |
10. | Anakinra | Phase 3 | NCT04412291 | Anti-inflammatory | [178] |
11. | Ivermectin | Completed | NCT04422561 | Antiparasitic | [179] |
12. | Budesonide dry powder inhaler | Phase 2 | NCT04416399 | Corticosteroid | [180] |
13. | LY3819253 | Phase 3 | NCT04427501 | Corticosteroid | [181] |
14. | Atazanavir and dexamethasone | Phase 3 | NCT04452565 | Corticosteroid and antiviral | [182] |
15. | Colchicine | Phase 2 | NCT04326790 | Anti-inflammatory | [183] |
16. | Corticosteroid | Phase 3 | NCT04381936 | Corticosteroid | [184] |
17. | Azithromycin | Phase 3 | NCT04381936 | Antibacterial | [184] |
18. | Convalescent plasma | Phase 3 | NCT04425915 | Convalescent plasma | [130] |
19. | NA-831 and dexamethasone | Phase 3 | NCT04452565 | Corticosteroid | [182] |
20. | Camostat Mesilate | Phase 2 | NCT04470544 | Protease inhibitor | [81] |